Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Clinical trials

Tools & Techniques Clinical trials

Insights Management: the Next Phase of Clinical R&D Gains

| Tony Page | 5 min read

Current approaches to R&D tech investment are not helping life science companies. How can the situation be improved?

Disease Area Cancer

Demystifying Cancer R&D

| Maryam Mahdi | 5 min read

Clinical trials? Cancer R&D? AstraZeneca’s Matthew Ellis shares his views on the future of pharma.

Outside the Lab Professional development

Hurdles and High Jumps – Chapter 1: There Is No Yellow Brick Road

| Rich Whitworth | 4 min read

Tim O’Meara – researcher, entrepreneur, strategist – considers the translational journey ahead

Tools & Techniques Clinical trials

Trials on Trial

| Angus Stewart | 8 min read

Clinical trials suffer from heavy dropout rates. Perhaps the answer is a little care and attention.

Tools & Techniques Clinical trials

Data Damage

| Angus Stewart

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.

Research Field Drug discovery

Meet the Microbiome Matchmaker

A 2000-participant study in Europe has examined how drugs – and combinations of drugs – can affect the microbiota in our gut.

Research Field Neuroscience

We Need to Talk About Clinical Representation

Alzheimer’s research should benefit all, regardless of ethnicity or race

Tools & Techniques Clinical trials

The SCOPE of Things to Come

| Paulo Eduardo Stanga

It is your responsibility to encourage patients to join the SCOPE study

Research Field Clinical trials

A Rare Opportunity for Change

| Maryam Mahdi

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.

Tools & Techniques Clinical trials

Trials, Interrupted

| Carl D. Regillo

Chief of the Retina Service at Wills Eye Hospital discusses the impact of COVID-19 on retina research


Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register